Zora Biosciences Licenses Ceramide Technology to Quest Diagnostics
Quest plans to develop a test service based on Zora's ceramide technology as an aid in identifying patients at risk for cardiovascular-related disease and death.
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
Randox Introduces sPLA2-llA Assay for Clinical Chemistry Analyzers
Measurement of patient sPLA2-llA levels enables clinicians to gain a comprehensive overview of cardiovascular risk factors and can help them tailor treatment accordingly.
Cardiovascular
LatestNumares and Mayo Clinic Laboratories Collaborate on Nuclear Magnetic Resonance Diagnostics
The new pathways will focus on conditions such as cardiovascular disease, kidney disease, and liver cancer.
Cardiovascular Disease Diagnostics and Testing
Current and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreGD Biosciences Expands Cardiac Test Availability
Global demand for the company’s heart disease blood test prompts international expansion.
Read More
Study Signifies Progress for Cardiovascular Disease Treatment and Personalized Medicine
The DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read MoreTroponin I Assay, Analyzer Designed for Quick Diagnoses at Point of Care
The assay delivers cardiac troponin I results in about 15 minutes from either whole blood or plasma samples.
Read MoreGenetic Testing Panel Investigates Inherited Cardiovascular Diseases
The next-generation sequencing based molecular test detects genomic variations in 213 genes related to familial cardiovascular diseases.
Read More
Study Recommends Change in Use of Troponin as Heart Attack Marker
Research recently published in Clinical Biochemistry identifies the precise magnitude of change in cardiac troponin required for early diagnosis of myocardial infarction.
Read More
Lipid Screening for Cardiovascular Disease
Developments in lipid testing over recent years may signal a better alternative to taking cholesterol levels when it comes to evaluating patients at risk for cardiovascular events.
Read More
Magnisense Receives €1.2 Million to Develop Emergency Diagnostic Tests for Cardiovascular Diseases
Financing from the French public investment bank Bpifrance will fund Magnisense’s MI² project to develop emergency cardiovascular diagnostics using magnetic nanomaterials.
Read More
November 2014 Tech Guide: Cardiovascular Testing
CLP’s November 2014 Tech Guide features cardiovascular testing products from vendors such as Beckman Coulter, Randox Laboratories, Roche Diagnostics, and Siemens Healthcare Diagnostics.
Read More
Study Boosts Benefits of Cardiovascular Inflammatory Testing
ISPOR presentation validates significant clinical benefits and cost savings for US health plans through routine testing for cardiovascular risk markers of vascular inflammation.
Read More
Personalizing Cardiology
The healthcare system spends significant resources managing the fallout from a cardiac event, but comparatively little is spent to assess risk beforehand.
Read MorePatients Managed to Target LDL Particle Number Experience Fewer Cardiovascular Events
Data released at the American College of Cardiology annual scientific sessions suggest that a diagnostic strategy using nuclear magnetic resonance technologies can improve cholesterol management and reduce incidence of cardiovascular events.
Read More
Cardiovascular Testing
Laboratory testing plays a vital role in keeping tabs on aging women.
Read MoreCardiac Biomarker Distinguishes Hypertension and Heart Failure
The Presage ST2 immunoassay from Critical Diagnostics can detect the cardiac biomarker ST2 and help differentiate hypertensive heart failure (HHF) patients from those with hypertension (HT) with or without left ventricular hypertrophy (LVH), according to a new study published in the Journal of Human Hypertension.
Read More
Atherotech Adds Trio of Genetic Tests to Cardiometabolic Test Menu
Warfarin, Plavix sensitivity tests, and thrombophilia risk test provide personalized risk assessment, diagnosis, and treatment.
Read More